Incretins: all 1,182 studies that test it
Page 12 of 12. Open to participants first (46), then studies with results posted, then the rest; newest registration first within each.
- Effect of Sitagliptin on Postprandial Lipoprotein MetabolismTerminatedNCT00939939Phase 4
- Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy SubjectsCompletedNCT00935467Phase 1
- Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes MellitusCompletedNCT00923962Not applicable
- GLP 1 for Intraoperative Glycemic ControlCompletedNCT00882492Phase 1
- Examination of the Effects of Liraglutide on the Mode of Action of Insulin DetemirCompletedNCT00873223Phase 1
- The Effects of Exenatide After Gastric RestrictionStatus unknownNCT00872378Phase 2/3
- Characterization of Beta Cell FailureWithdrawnNCT00869102Not applicable
- Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic PatientsCompletedNCT00859079Phase 4
- A Phase 2 Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT00857558Phase 2
- Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic SyndromeCompletedNCT00856700Not applicable
- MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes MellitusCompletedNCT00854035Phase 3
- Effect of Sitagliptin on Graft Function Following Islet TransplantationTerminatedNCT00853944Phase 3
- Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to DysinsulinismCompletedNCT00847080Phase 4
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young AdultsWithdrawnNCT00845559Phase 4
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy SubjectsCompletedNCT00842556Phase 1
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCICompletedNCT00835848Phase 4
- Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male SubjectsCompletedNCT00822003Phase 1/2
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy IndividualsCompletedNCT00813228Phase 1
- Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes MellitusCompletedNCT00798915Phase 1
- Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of SaxagliptinCompletedNCT00770302Phase 1
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureCompletedNCT00766857Phase 4
- Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During RamadanTerminatedNCT00766441Phase 4
- To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or PlaceboCompletedNCT00761540Phase 1
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PETCompletedNCT00747968Phase 2/3
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.CompletedNCT00747383Not applicable
- PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatideCompletedNCT00744224Not applicable
- Sitagliptin in Renal Transplant RecipientsCompletedNCT00740363Phase 4
- Bone Turnover in Type 2 Diabetes PatientsStatus unknownNCT00732121Phase 4
- Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic SyndromeCompletedNCT00721552Not applicable
- Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative StressStatus unknownNCT00699322Phase 4
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and InflammationStatus unknownNCT00696982Not applicable
- A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)CompletedNCT00696826Phase 1
- Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular AxisCompletedNCT00683735Phase 2/3
- Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy SubjectsCompletedNCT00672399Phase 1
- Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial InfarctionCompletedNCT00650143Phase 2/3
- An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)CompletedNCT00642798Phase 1
- Beta-cell Function in Glucose Abnormalities and Acute Myocardial InfarctionCompletedNCT00627744Phase 4
- Beta-Cell Function After Near-Normalisation of Blood GlucoseCompletedNCT00612950Not applicable
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 DiabetesCompletedNCT00612794Phase 1
- Near Normalisation of BG Improves the Potentiating Effect of GLP-1CompletedNCT00612625Not applicable
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesWithdrawnNCT00572689Phase 4
- Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes MellitusCompletedNCT00551590Phase 1
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi SyndromeCompletedNCT00551343Not applicable
- Effects of Sitagliptin on Gastric Emptying in Healthy SubjectsCompletedNCT00501657Phase 1
- A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)CompletedNCT00481663Phase 2
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusCompletedNCT00477581Phase 4
- Sitagliptin Treatment in Patients With Type 2 DM After Kidney TransplantCompletedNCT00466518Not applicable
- Sitagliptin in the ElderlyCompletedNCT00451113Phase 2
- Effect of Januvia on Beta Cell Function in Patients With Diabetes MellitusCompletedNCT00425490Phase 3
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During HypoglycemiaCompletedNCT00418288Not applicable
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesCompletedNCT00382239Phase 2
- Safety and Efficacy of Exenatide as MonotherapyCompletedNCT00381342Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363948Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363844Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363519Phase 3
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesCompletedNCT00359879Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminCompletedNCT00324363Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.CompletedNCT00313001Phase 3
- Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart FailureCompletedNCT00264199Not applicable
- In-patient Study in Patients With Type 2 Diabetes MellitusCompletedNCT00259896Phase 1
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy MenCompletedNCT00256256Not applicable
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCompletedNCT00254800Phase 1
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesCompletedNCT00241423Phase 2
- GIP: Glucose-dependent Insulinotropic PeptideCompletedNCT00239707Phase 1
- Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 DiabetesCompletedNCT00154414Phase 2
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00154401Phase 2
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCompletedNCT00111540Phase 3
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 DiabetesCompletedNCT00103935Phase 2
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCompletedNCT00099619Phase 3
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsCompletedNCT00099333Phase 2
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminCompletedNCT00099320Phase 3
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00085969Phase 2
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00044694Phase 2
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCompletedNCT00044668Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaCompletedNCT00039026Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCompletedNCT00039013Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00035984Phase 3
- NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 DiabetesCompletedNCT00013910Phase 1